Bede Compounds

Bede’s Promise  :8x Third-Party Tested   |   Batch-Specific COAs    |   99%+ purity   |   $100 = Free Shipping   | 1 Peptide Vial = 1 Free BAC Water Vial

← Back to research

RESEARCH LIBRARY

Wolverine — Research overview

Co-formulated BPC-157 and TB-500 for tissue repair research workflows. Manufactured to high-purity standards.

Wolverine (BPC-157 / TB-500)

Dual blend of BPC-157 and TB-500 (a thymosin beta-4 fragment)

Studied in tissue-repair and recovery research models

BPC-157 component investigated for cytoprotective and angiogenic activity

Stable gastric pentadecapeptide in research

TB-500 component referenced for actin regulation and cell migration

Studied in connective-tissue research

Research Use Notes

Supplied as lyophilized powder

Requires reconstitution before use

Research Water required for mixing (sold separately)

Swirl gently, never shake

Storage

Store lyophilized vial frozen for extended holding

Keep reconstituted blend at 2 to 8°C

Refrigerated solution stable for up to 21 days

Handling

Maintain sterile technique during reconstitution

For laboratory research use only

Compound Information

Molecular profile

What is Wolverine(Do Not Order — Currently Under Testing)?

Type
Tissue-repair peptide blend
BPC-157
Pentadecapeptide
TB-500
Thymosin β4 fragment

Storage requirements

Stability Information

Avoid freeze/thaw cyclesProtect from lightKeep refrigerated
Lyophilized (powder)-20°C24+ months
Reconstituted2-8°C~30 days

Sources & References

Shopping cart

Select size

Certificate of Analysis

BEDE COMPOUNDS

Researcher Declaration

Bede Compounds sells research material exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.

Not a researcher?

Research-use confirmation

By continuing, I confirm that I have read, understood and accept the following policies: